• Mashup Score: 0

    KEY TAKEAWAYS Bispecific antibodies, such as talquetamab, represent a transformative shift in cancer treatment, offering the potential to target two antigens simultaneously and more effectively involve the immune system in the fight against cancer. Talquetamab, a first-in-class GPRC5DxCD3 bispecific antibody, ha…

    Tweet Tweets with this article
    • We explore the power of bispecific #antibodies, spotlighting the promising therapy, Talquetamab, and its groundbreaking impact on multiple myeloma treatment. Plus, get insights from leading oncology expert, Dr. Carolina Schinke. #BispecificAntibodies https://t.co/cXWdHcYxlw https://t.co/YBRIej6ca3